Background/Aims: This study investigated the effect of inducible nitric oxide synthase-loaded mineralized nanoparticles (iNOS-MNPs) on the osteogenic differentiation of mouse embryonic stem cells (ESCs). Methods: We prepared iNOS-MNPs using an anionic block copolymer template-mediated calcium carbonate (CaCO 3 ) mineralization process in the presence of iNOS. iNOS-MNPs were spherical and had a narrow size distribution. iNOS was stably loaded within MNPs without denaturation. In order to confirm the successful introduction of iNOSMNPs into the cytosol of ESCs, intracellular levels of nitric oxide (NO) was determined with a fluorometric analysis. A NO effector molecule, cyclic guanosine 3',5' monophosphate (cGMP) was also quantified with a competitive enzyme immunoassay. Cell viability in response to iNOS-MNP treatment was determined using the cell counting kit-8 (CCK-8) assay. Alkaline phosphatase (ALP) activity assay, intracellular calcium quantification assay, and Alizarin red S staining for matrix mineralization were performed to investigate osteogenic differentiation of ESCs. The protein levels of Runt-related transcription factor 2 (RUNX2), osteocalcin (OCN), and osterix (OSX) as osteogenic-related factors were also assessed by immunofluorescence staining and Western blot analysis. The complex pathways associated with iNOS-MNP-derived osteogenic differentiation of ESCs were evaluated by network-based analysis. Results: Cells with iNOS-MNPs displayed a significant increase in NO and cGMP concentration compared with the control group. When cells were exposed to iNOS-MNPs, there were no adverse effects on cell viability. Importantly, iNOS-MNP uptake promoted the osteogenic differentiation of ESCs. Using transcriptome profiling, we obtained 1,836 differentially-induced genes and performed functional enrichment analysis with ClueGO and KEGG. These analyses identified significantly enriched and interconnected molecular pathways such as protein kinase activity, estrogen receptor activity, bone morphogenetic protein (BMP) receptor binding, ligand- 
Introduction
Nitric oxide is a highly reactive free radical produced from a guanidino-nitrogen of l-arginine by three isoforms of nitric oxide synthases (NOS), including endothelial NOS (eNOS), neuronal NOS (nNOS), and inducible NOS (iNOS), depending on tissue location and physiological function [1] [2] [3] . Specifically, iNOS and eNOS are expressed in bone marrow stromal cells, osteoblasts, osteocytes, and osteoclasts, whereas nNOS expression is restricted to the bone lining cells and osteoclasts [4] . While all three NOS isoforms have been implicated in the bone healing process [5] [6] [7] iNOS is the principal isoform involved in the stimulation of osteoblasts by NO production [8] [9] [10] .
NO is a signaling molecule that mediates a number of physiological events [11, 12] . NO has been shown to play an important role in bone formation and healing processes and can be generated by many cell types present in the bone milieu, most significantly, the osteoblasts [13] . However, whether NO results in pluripotent stem cell commitment into the osteogenic lineage has not been characterized.
NO-induced cyclic guanosine 3',5' monophosphate (cGMP) plays an important role in the early lineage specification of embryonic stem cells (ESCs) [14, 15] . ESCs treated with high concentrations of a chemical NO donor downregulated pluripotent gene expression and promoted differentiation events [16] . A number of groups have demonstrated that NO encourages the differentiation of bone marrow-derived mesenchymal stem cells (MSCs) into osteoprogenitor cells [17] [18] [19] . However, whether NO is associated with the osteogenic differentiation of ESCs in vitro remains largely unknown [20, 21] .
NO is an important cellular signaling molecule that regulates stem cell fate. However, NO exists as a gas, which limits its use for research. Thus, NO-generating chemical compounds have been developed as NO donors and utilized in vitro and in vivo [22, 23] , but are inconvenient due to their short half-life, cell toxicity, and low stability. In this study, we developed iNOS-loaded nanoparticles, which are manufactured through non-toxic processes using biocompatible polyethylene glycol (PEG)-poly L-aspartic acid (PAsp) block copolymerinduced mineralization for controlled, intracellular NO generation. Intracellular delivery of functional proteins, including enzymes, regulates various cellular events and has therapeutic applications in animal studies [24, 25] . The stable delivery and controlled release of iNOS enzyme in cells and the sustained production of NO molecules may mimic physiological NO production. Therefore, our system can overcome the limitations of current methods of NO application in biological experiments.
Nanomaterials can control stem cell behavior and tissue regeneration. Therefore, organic and inorganic nanoparticles are commonly used in stem cell research [26] . In this way, establishment of nanomaterial-based methodologies for ESC differentiation may provide a real-time toolkit for exploring a role for stem cell differentiation in cell therapy. In the present study, we demonstrate the effective delivery of iNOS-loaded nanoparticles into ESCs. Additionally, using global gene expression profiling for iNOS-MNP-mediated ESC osteogenesis, we assess the pro-osteogenic impact of iNOS-mediated NO production on ESCs and the activation of intracellular NO-related signaling pathways.
Fabrication of iNOS-loaded CaCO 3 -Mineralized Nanoparticles (iNOS-MNPs).
iNOS was loaded into the CaCO 3 -mineralized nanoparticles by the PEG-PAsp-templated mineralization process as follows. To a stirred aqueous PEG-PAsp solution (2.5 mg/mL, pH 8.0), an aqueous solution of calcium chloride (2 mL, 0.037 mmol, pH 8.0) was added at room temperature. After 2 h, an aqueous solution of iNOS (20 UN, pH 8.0) was added into the solution, and the solution mixture was stirred at 500 rpm for 3 h. Then, the aqueous solution of sodium carbonate (0.037 mmol, pH 8.0) was slowly mixed, and the mixture was vigorously stirred at 1, 000 rpm at 4°C for 24 h. After centrifugation at 3, 000 rpm for 3 min, the supernatant was placed into a membrane bag for dialysis against doubly distilled water (pH 8.0, molecular weight cut-off (MWCO): 100, 000 g/mol) for 12 h, followed by freeze-drying. For calculation of the loading amount of iNOS in the iNOS-MNPs, the iNOS-MNPs were completely dissolved in doubly distilled water (pH 5.0), and the iNOS was quantified using a quantification assay kit for iNOS.
Characterization of the iNOS-MNPs
Dynamic light scattering measurements were performed using a 90 Plus particle size analyzer (Brookhaven Instruments Corporation) equipped with a vertically-polarized He-Ne laser (632.8 nm). The hydrodynamic diameter (d) and polydispersity factor (PDF) of the iNOS-MNPs were calculated using the Stokes-Einstein equation and the cumulant method, respectively [Harada A]. The morphology of the iNOSMNPs was examined by transmission electron microscopy (TEM; H-7100, HITACHI, Japan), operating at an acceleration voltage of 100 kV. For the observation of size and morphology of the iNOS-MNPs, a drop of sample solution (concentration = 1 g/L) was placed onto a 200-mesh copper grid coated with carbon. About 5 min after deposition, the grid was tapped with a filter paper to remove surface water, followed by airdrying. Fourier transform infrared (FT-IR) spectra of the iNOS-MNPs were obtained using a Spectrum One System FT-IR spectrometer (Perkin Elmer, New York, USA) in the range of 450 to 2000 cm −1 at a resolution of 4 cm -1 .
Estimation of pH-dependent catalytic activity of iNOS-MNPs for NO generation
The activities of the iNOS-MNPs for NO generation were evaluated by estimating the nitrite generation in a HEPES-buffered solution (20 mM, 0.5 mM EDTA) at pH 7.4 and 5.0 at 37°C. The iNOS-MNPs were dispersed in buffer solutions (1 mL, 1 mg/mL) at pH 7.4 and 5.0, and the time-dependent nitrite generation was quantified using an ultrasensitive colorimetric assay kit for iNOS (NB78, Oxford Biomedical Research Inc.). The medium was shaken at a speed of 100 rpm at 37°C. At pre-determined time intervals, samples (100 μl) were withdrawn and replaced with an equal volume of the fresh medium. The nitrite concentration was determined by interpolation from the nitrite standard curve.
pH-dependent dissolution of iNOS-MNPs
To study iNOS release, in vitro dissolution behavior of iNOS-MNPs was estimated in the buffer solutions (pH 7.4 and pH 5.0). The iNOS-MNP solution (1 mg/mL) was placed in a dialysis membrane bag (MWCO: 3, 500 g/mol) and was shaken at 100 rpm at 37°C in the release medium. The release medium (10 mL) was withdrawn at predetermined time intervals and replaced with an equal volume of the fresh medium. The release rate of calcium ions was monitored by diluting 100 μl of sample with the Arsenazo III solution (2 . The ESCs were cultured in Dulbecco's modified Eagle's medium (DMEM) (Gibco-BRL, USA) supplemented with 17.5 mM glucose, 1.7 mM L-glutamine, 0.1 mM β-mercaptoethanol, 5 ng/ml mouse leukemia inhibitory factor (LIF, Enzo Life Sciences, USA), 15% FBS, and 1% penicillin and streptomycin (Gibco-BRL, USA), without a feeder layer at 37°C in an atmosphere containing 5% CO 2 . To form embryoid bodies (EBs), the cells were dissociated by 0.05% trypsin/EDTA (Gibco-BRL, USA). Then, 2, 000 cells were hung from the lids of 150 mm culture dishes for 2 days in 20 μl DMEM without LIF. EBs were then suspended in additional medium for 3 days. Thus, EBs cultured for 5 days old were used in this experiment.
Osteogenic differentiation of ESCs
ESC differentiation was performed as previously reported. EBs were plated onto gelatin-coated 60-mm dishes (10-15 EBs per well) and maintained in an osteogenic medium consisting of DMEM with 5% FBS, 50 μg/mL ascorbic acid, 1 μM dexamethasone, and 3 mM β-glycerophosphate for 2 days before the application of iNOS-MNPs. To promote osteogenic differentiation, iNOS-MNPs at different concentrations (0 to 100 μg/ml) were added to the osteogenic medium, which was changed every other day.
Measurement of nitric oxide
4-Amino-5-methylamino-2',7'-difluorofluorescein diacetate (DAF-FM DA) was used for fluorescence microscopy of NO and measurements of NO production. For microscopy studies, EBs were cultured in 6-well plates and treated for the indicated times with different drug concentrations. Cells were washed and phenol red-free media was added, and then cells were incubated with DAF-FM DA (5 μM) for 10 min in the dark. Cells were then washed twice with ice-cold phosphate-buffered saline (PBS) and fixed with 2% paraformaldehyde for 3 min and washed twice again with ice-cold PBS. Analysis of NO production was carried out using a fluorescence microscope (Fluoview 300, Olympus, Japan) with the excitation wavelength set at 480 ± 10 nm and the emission wavelength at 505 ± 10 nm. For fluorometry experiments, cells were cultured with iNOSMNPs (10 μg/ml). After 24, 48, and 72 h, cells were washed twice with ice-cold PBS and incubated with DAF-FM DA (5 μM) at 37°C. Following incubation for 1 h, NO levels were determined by fluorescence readings using a fluorometer (Triad, DYNEX, Austria) with the excitation and emission wavelengths set at 490 nm and 515 nm, respectively. 'No dye' controls were used as background fluorescence and were subtracted from 'all dye'-containing sample well readings.
Measurement of cGMP levels
The cells were incubated for 2 days in osteogenic differentiation media containing different concentrations of iNOS-MNPs. Cells were washed three time with PBS and lysed in lysis buffer from the cGMP ELISA kit (CELL BIOLABS, USA.). Total protein content was quantified using the Bradford method [27] . The cGMP content was measured using a cGMP ELISA kit according to the manufacturer's instructions and the absorbance was read at 450 nm using a spectrophotometer. The cGMP content level was expressed as pmol/mg of protein.
Cell Viability assay
Cell viability was analyzed by using the cell counting kit-8 (CCK-8) assay. Briefly, EBs were seeded into 60-mm culture dishes. After 24 h, cells were changed to DMEM medium containing 5% FBS, and maintained for 24 h. Then, cells were incubated with different concentrations of iNOS-MNPs (0-100 µg/ ml) for 24 or 48 h. After exposure, CCK-8 solution was added for 1 h and the assay was performed following the manufacturer's instructions. The optical density of each well was determined at a wavelength of 450 nm using an ELISA plate reader (Triad, DYNEX, Austria). The percentage of cell viability was calculated relative to the control.
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Measurement of ALP activity Cells were plated onto gelatin-coated 60-mm dishes (10-15 EBs per well). After 48 h since seeding, cells were changed into osteogenic differentiation medium containing different concentration of iNOS-MNPs (0-100 μg/ml). Total cells were lysed in 50 mM Tris-HCl buffer (pH 7.0) containing 1% (v/v) Triton X-100 and 1 mM phenylmethylsulfonyl fluoride (PMSF). Total protein content was quantified using the Bradford assay. ALP activity was evaluated at 4 and 7 days by using p-nitrophenylphosphate (pNPP) method. The cell lysate was assayed by adding 200 µl of pNPP as a substrate (Sigma) for 30 min at 37°C. The reaction was stopped by adding 3M NaOH, and the result was read at a wavelength of 405 nm using a spectrophotometer. The enzyme activity was expressed as mM/100 µg of protein.
Intracellular calcium quantification assay
Cells were plated onto gelatin-coated 60-mm dishes (10-15 EBs per well). Forty -eight hours after seeding, cells were changed into osteogenic differentiation medium containing different concentration of iNOS-MNPs (0-100 μg/ml). After 14 days, cells were washed three times using PBS and lysed in 50 mM TrisHCl buffer (pH 7.0) containing 1 mM PMSF and 1% (v/v) Triton X-100 without EDTA. Total protein content was quantified using the Bradford method. Intracellular calcium was measured using a calcium assay kit according to the manufacturer's instructions. The absorbance was read at 612 nm using an ELISA plate reader. The calcium content level was expressed as mM/100 mg of protein.
Alizarin red S staining
Cells were plated onto gelatin-coated 12-well culture plates (5 EBs per well) and incubated in osteogenic medium for 21 days. The culture media was aspirated and washed three times with PBS. Cells were fixed in 4% paraformaldehyde for 20 min, washed three times with ice-cold PBS, and stained with 2% alizarin red S solution (pH 4.2) for 5 min at room temperature. Finally, the alizarin red S solution was aspirated and washed with deionized water. The samples were observed under a light microscope.
RNA isolation and real-time reverse transcriptase-polymerase chain reaction (RT-PCR)
Gene expression of Mmp15, Cltb, Atp5s, Cadn4, Wnt9a, Bmp8a, Fgf11, Map4k1 were analyzed by using real-time RT-PCR. Total RNA was extracted from different groups at 4 days by using the TRIzol reagent, following the manufacturer's instructions. cDNA was synthesized using the cDNA synthase kit (Bioneer, Korea) in accordance with the manufacturer's instructions. Real time RT-PCR was performed in the RotorGene 2000 real-time thermal cycling system (Corbett Research, Sydney, Australia) using a QuantiTect SYBR Green RT-PCR kit (Enzo, USA). The mouse primers used were 5′-ATC TGG CGG TCT GGA AGA AC-3′ (forward), 5′-AGG CTG CCC AAA ATC CAA TC-3′ (reverse) for Mmp15, 5′-CTT TCA CCC CAC AAC TCC TT-3′ (forward), 5′-CAC AAT TGA GTG GGC TGA CA-3′ (reverse) for Cltb, 5′-TCA CTG CTG GAA TCC ACT GT-3′ (forward), 5′-AAA TCC CGG GAA GCC ATA C-3′ (reverse) for Atp5s, 5′-CCC TCT CCC CCC ATT ACT G-3′ (forward), 5′-GCC CCG TAC AAA AAT GTG TT-3′ (reverse) for Cadn4, 5′-TCT TGT GCA GCC TGT GAT TT-3′ (forward), 5′-TTC TCT GCA GTC ACT CAG GTT-3′ (reverse) for Wnt9a, 5′-CAG CCA AAG AAA ACG AAC GA-3′ (forward), 5′-AAC CGT GGC CAT CAT CAA AG-3′ (reverse) for Bmp8a, 5′-ACC CCC AAC TCA GCA ATA AG-3′ (forward), 5′-GAG GCT CCT CGT TTC CTA AG-3′ (reverse) for Fgf11, 5′-ATT GGG ACA CCG TAC TGG AT-3′ (forward), 5′-TGT CGC ACA GCT CAT TGT AT-3′ (reverse) for Map4k1, 5′-TGC ACC ACC AAC TGC TTA G-3′ (forward), 5′-GGA TGC AGG GAT GAT GTT C-3′ (reverse) for GAPDH. The reaction mixture contained 1 µg of the total RNA and 0.5 µM of each primer. Real-time RT-PCR was performed using the Rotor-Gene 2000 cycler program: 30 min at 50°C for reverse transcription; 15 min at 95°C for DNA polymerase activation; 15 sec at 95°C for denaturing; and 45 cycles of 15 sec at 94°C, 30 sec at 60°C, and 30 sec at 72°C. Data collection was carried out during the extension step (30 sec at 72°C). RNA expression levels of target genes were normalized to control GAPDH RNA expression. The temperature of the PCR products was increased from 65 to 99°C at a rate of 1°C/5 sec, and the resulting data was analyzed using the software provided by the manufacturer. RUNX2) and overnight incubation at 4°C. Subsequently, cells were treated with Alexa Fluor 488 or 594 goat anti-rabbit immunoglobulin G (IgG) (1∶500, Invitrogen Life Technologies, USA) for 2 h at room temperature. Fluorescence images were obtained using a fluorescence microscope (Fluoview 300, Olympus, Japan).
Western blot analysis
The cells were incubated for 7 days in osteogenic differentiation medium containing different concentrations iNOS-MNPs. Whole cells were lysed using RIPA buffer with protease inhibitor and protein contents were quantified using the Bradford procedure. Protein extracts (30 µg) were separated by 10% sodium dodecyl sulfate polyacrylamide gel and blotted onto polyvinylidene difluoride (PVDF) membranes. The blots were washed with 10 mM Tris-HCl (pH 7.6), 150 mM NaCl, 0.05% Tween-20 (TBST), blocked with 5% skim milk for 1 h and incubated with the appropriate primary antibodies (anti-OCN, anti-OSX, and anti-β-actin) at the dilutions recommended by the supplier at 4°C overnight. The membranes were then washed and the bound primary antibodies were detected with goat anti-rabbit IgG or goat anti-mouse IgG conjugated to horseradish peroxidase. The blots were developed with enhanced chemiluminescence (BioRad Laboratories, USA) and exposed to X-ray film (Eastman-Kodak, Rochester, NY, USA).
RNA isolation and library preparation and sequencing
Total RNA was isolated using TRIzol reagent (Invitrogen). RNA quality was assessed using the Agilent 2100 bioanalyzer with the RNA 6000 Nano Chip (Agilent Technologies, Amstelveen, The Netherlands), and RNA quantification was performed using ND-2000 Spectrophotometer (Thermo Inc., DE, USA). For control and test RNAs, library construction was performed using the SENSE 3′ mRNA-Seq Library Prep Kit (Lexogen, Inc., Austria) according to the manufacturer's instructions. Briefly, 500 ng total RNA was used and an oligodT primer containing an Illumina-compatible sequence at its 5′ end was hybridized to the RNA prior to reverse transcription. After degradation of the RNA template, second strand synthesis was initiated by a random primer containing an Illumina-compatible linker sequence at its 5′ end. The double-stranded DNA library was purified by using magnetic beads to remove all reaction components. The library was amplified to add the complete adapter sequences required for cluster generation. The finished library is purified from PCR components. High-throughput sequencing was performed as single-end 75 sequencing using NextSeq 500 (Illumina, Inc., USA).
Data analysis SENSE 3′ mRNA-Seq reads were aligned using Bowtie2 version 2.1.0 (Langmead and Salzberg, 2012). Bowtie2 indices were either generated from genome assembly sequences or the representative transcript sequences for aligning to the genome and the transcriptome. The alignment file was used for assembling transcripts, estimating their abundances and detecting differential expression of genes. Differentially expressed genes were determined based on counts from unique and multiple alignments using EdgeR in R version 3.2.2 (R development Core Team, 2011) using BIOCONDUCTOR version 3.0 [28] . The read count (RT) data were processed based on quantile normalization method using the Genowiz ™ version 4.0.5.6 (Ocimum Biosolutions, India). Cytoscape (version 2.7), an open-source bioinformatics platform developed by the Institute of Systems Biology (Seattle, WA) was used to construct network diagrams and to illustrate clustering of the genes in our dataset within specific pathways. Gene classification was based on searches done by DAVID (http://david.abcc.ncifcrf.gov/) and Medline databases (http://www.ncbi.nlm.nih.gov/). Experimental data were integrated and analyzed using ClueGO application within the Cytoscape plug-ins. ClueGO functional analysis was performed using Gene Ontology or using the Kyoto Encyclopedia of Genes and Genomes (KEGG).
Statistical analysis
All data are expressed as mean ± standard deviation (S.D.). One-way ANOVA was used for multiple comparisons, using SPSS software v. 10.0. P values < 0.05 were considered significant.
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Results
Fabrication and characterization of iNOS-loaded mineralized nanoparticles
The iNOS-MNPs were fabricated using a PEG-PAsp-templated CaCO 3 mineralization approach developed in our laboratory [29] . The addition of Ca 2+ and CO 3 2-ions to a stirred solution of PEG-PAsp induced ionic supersaturation around the anionic moieties of the PAsp blocks. This process induced the nucleation and growth of a crystalline CaCO 3 core, while the PEG block formed the hydrated shell domains. During this mineralization process, iNOS could be loaded in situ within the CaCO 3 core through ionic interaction. The mean hydrodynamic diameter of the iNOS-MNPs estimated by dynamic light scattering analyses was 333.9 ± 10.2 nm with a narrow polydispersity factor (0.11) (Fig. 1A) . TEM analysis revealed that the iNOSMNPs have a spherical shape (Fig. 1B) . The loading efficiency of iNOS in the iNOS-MNPs was estimated to be 35.1%. For iNOS loading, the loading approach that does not induce the denaturation of iNOS is critical for stable iNOS delivery into ESCs. FT-IR analysis showed that the iNOS-MNPs showed vibration bands at 877 cm −1 , which was attributed to the v 2 (out-ofplane bending mode) bands of vaterite (Fig. 1C) . We also observed the vibrational band at 1420 cm −1 attributed to v 3 asymmetric stretching mode of the vaterite CaCO 3 .
pH-dependent catalytic activity of iNOS-MNPs for NO generation
We used the assay kit employing recombinant nitrate reductase for conversion of nitrates to nitrites prior to quantification of nitrite using the Griess reagent, thereby accurately evaluating overall iNOS activity. The pH-dependent catalytic activity of the iNOS-MNPs for 
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NO generation was estimated by evaluating the activity for generation of nitrite at both the extracellular pH (7.4) and the endosomal pH (5.0). Fig. 1D shows the pH-dependent nitrite generation profiles at pH 7.4 and 5.0. It is noteworthy that the nitrite generation at pH 5.0 is more pronounced compared with that at pH 7.4. This enhanced nitrite generation at pH 5.0 indicates that a large amount of iNOS was released from the iNOS-MNPs, thus effectively catalyzing the oxidation of L-arginine to generate NO molecules. The improved activity at endosomal pH may indicate that the iNOS-MNPs can effectively generate NO molecules after internalization into ESCs. This indicates that iNOS was stably loaded within the CaCO 3 cores and also released, while maintaining its inherent activity. To support the pH-dependent catalytic iNOS activity for NO generation, the kinetics of CaCO 3 dissolution from the iNOSMNPs was examined. As shown in Fig. 1E , at endosomal pH, CaCO 3 dissolution was facilitated, whereas CaCO 3 dissolution was found to be inhibited at an extracellular pH. Accelerated dissolution of the CaCO 3 core at endosomal pH was expected because the solubility of CaCO 3 increases in proportion to the concentration of protons (H + ) [30] . Facilitated dissolution of CaCO 3 at the endosomal pH triggered preferential iNOS release within ESCs, thereby resulting in the enhanced NO generation.
Effect of iNOS-MNPs on intracellular NO levels
To verify whether NO is successfully generated when cells uptake iNOS-MNPs, intracellular NO production is evaluated by using the cell-permeable fluorescent indicator DAF-FM DA for 24, 48, or 72 h. When cells stained with DAF-FM DA were recorded by fluorescence microscopy, fluorescence was much stronger in cells treated with iNOS-MNPs than in the control group (Fig. 2A) . Fluorescence intensity was higher in cells treated with iNOS-MNPs compared with control MNP-treated cells (without iNOS) at each time point 
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To verify the osteogenic effect of iNOS-MNP on ESCs, cells were exposed to 1-100 μg/ml of iNOS-MNPs for 7, 14, or 21 days. ALP activity, [Ca 2+ ] i , and mineralization was then determined. Fig. 3B and C demonstrate that ALP activity and [Ca 2+ ] i were significantly enhanced in ESCs exposed to iNOS-MNPs. Cells treated for 21 days with iNOS-MNPs displayed highly positive Alizarin red S staining, suggesting high calcium nodule formation and matrix mineralization as would be expected as a result of osteogenic differentiation (Fig. 3D) . To further identify osteogenic differentiation, we assessed the protein levels of osteogenic markers RUNX2, OCN, and OSX on day 7 of osteogenic induction. Immunofluorescence staining (Fig. 4A, B) and western blot analysis (Fig. 4C) confirmed that the treatment of iNOS-MNPs increased each osteogenic marker protein in ESCs compared with control group. These results suggest that the treatment of ESCs with iNOS-MNPs enhances osteogenic differentiation.
iNOS-MNPs alter ESC transcription profile
In order to investigate the changes in global gene expression by the iNOS-MNP-induced ESC differentiation, cells were treated with iNOS-MNPs for 14 days and high-throughput RNA-Seq analysis was performed. When a fold-change cut-off of >1.5 and a P value of <0.05 was applied to filter the differentially expressed genes in iNOS-MNP-treated cells compared to the control, we classified 730 genes as upregulated and 1, 106 as downregulated, which were clustered using the Euclidean distance correlation and visualized by a heatmap (Fig.  5A, B) . Table 1 
Identification of genes associated with osteogenic differentiation by iNOSMNPs
We next identified differentially expressed genes (P < 0.05, with foldchange >1.5) to extract the activation of bone-related molecular pathways by iNOS-MNP treatment, comprising a total of 537 genes, of which 337 were downregulated and 200 were upregulated using GO analysis (https:// www.ebi.ac.uk/QuickGO/) and ExDEGA (Excel-based Differentially Expressed Gene Analysis) version 2.3 tool (ebiogen, Korea) (Supplemental Data 2). Table 2 demonstrates the representative genes which were mapped to 14 different pathways such as cell differentiation, proliferation, extracellular matrix, BMP signaling, calcium ion binding, calciummediated signaling, mitogen-activated protein kinase (MAPK) cascade, Notch signaling, vasculature development, Wnt signaling, cell adhesion, growth factor activity, ossification, and skeletal system development, all of which are related to osteogenic differentiation and bone formation. The RNA-Seq data were validated by evaluating the expression of selected genes (Mmp15, Cltb, Atp5s, Cadn4, Wnt9a, Bmp8a, Fgf11, Map4k1) using real-time RT-PCR analysis. These genes were upregulated in a similar manner as that observed with RNA-Seq analysis, thus validating the RNA-Seq data (Fig. 6) .
Evaluation of the connectivity network between the differentially expressed genes
Network-based analysis within the differentially expressed genes relating to the osteogenic differentiation-related molecular pathways was further extracted by ClueGO. The molecular functions such as protein kinase activity, estrogen receptor activity, BMP receptor binding, ligand-gated ion channel activity, or phosphatidylinositol 3-phosphate binding were shown to be significantly enriched and interconnected (Fig. S1) . We next performed pathway enrichment analysis and identified the networks of three significantly enriched KEGG pathways along with the genes shared between these pathways (Fig. S2-A) . Fig. S2 -B illustrates the number of genes associated with each term in significant KEGG pathways. These analyses identify several pathways and genes with a connection to cellular mechanisms that are associated with NO-mediated ESC-osteogenic differentiation. 
Discussion
The present study determined the performance of iNOS-loaded nanoparticles on osteogenic differentiation and molecular function assessed using a genome-wide approach in ESCs. We first demonstrated successful intracellular iNOS/NO pathway induction by iNOS-MNP uptake and considerable effect of iNOS-MNPs-derived NO levels on differentiation of ESCs into osteogenic lineage, suggesting that NO can be a significant osteogenic cue in ESCs. NO plays an important role in osteogenesis, bone remodeling, and other metabolic mechanisms [13, 31, 32] . Several studies reported that NO stimulates the proliferation and differentiation of mesenchymal stem cells and calvarial osteoblasts [33, 34] . Treatment with a NO donor upregulates proliferation in human osteoblast cells and fetal calvarial osteoblasts [35, 36] . The crucial role of NO and NOS isoforms on ESC-osteogenic differentiation was previously reported and is comparable to our findings [20] . NO involvement in osteogenic development has been extensively explored, but how NO bioavailability impinges on the osteogenic program at the transcriptional levels has not been precisely elucidated.
We demonstrated that the increased NO levels induced by iNOS-MNPs influenced an extensive transcriptomic effect during the osteogenic differentiation process. Transcriptional analysis described differentially regulated pathways that may play important roles in NO-mediated osteogenic differentiation of ESCs. Among the activated pathways, MAPK signaling pathways promote the osteogenesis of stem cells in other experimental systems. Osteogenesis in human mesenchymal stem cells was improved by bioflavonoid treatment through the activation of c-Jun N-terminal kinase (JNK) and p38 MAPK pathways [37] . Inorganic nanoparticles such as those composed of gold or iron stimulate the osteogenesis of human periodontal ligament stem cells (PDLSCs) or human bone marrow stromal cells (BMSCs) in vitro via the p38 MAPK or extracellular signal-regulated kinase 1/2 (ERK1/2) activation [38, 39] . Similar to our results, co-activation of NO, BMP2, and MAPK pathways are involved in osteoblast proliferation and differentiation downstream of phytoestrogeninduced osteogenesis [40] . NO is known to induce osteogenesis of ESCs through activation of canonical Wnt signaling [21] . More recently, our group has reported that Wnt signaling is associated with the osteogenic differentiation of stem cells under various experimental conditions [41] [42] [43] . Based on previous studies and our present data, we suggest that NO can activate wide spectrum of signaling pathways involved in the osteogenic differentiation of stem cells. 
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This study also provides molecular insights into the network of differentially expressed genes that may act downstream of NO to induce osteogenesis in ESCs. Through functional enrichment, we identified that NO can induce multiple molecular pathways such as protein kinase activity, estrogen receptor activity, BMP receptor binding, ligand-gated ion channel activity, or phosphatidylinositol 3-phosphate binding. Consistent with our results, many studies have demonstrated the relationship between NO and estrogen receptor signaling in several biological processes including osteogenic development [44] [45] [46] . Moreover, BMP signaling-induced NO production stimulated bone calcification in zebrafish [47] . BMP receptor type II ligands (i.e., BMP-2 and BMP-4) can stimulate NOS activity [48] . Ultimately, when differentially expressed genes were assigned to pathways using the KEGG mapper, we found three NO-driven pathways, namely the Rap1 and PI3K-Akt signaling pathways, and focal adhesion, which links different pathways. Previous studies have reported the connection between NO and these signaling pathways in osteoblastic activity [49] [50] [51] [52] . Thus, we suggest that the NO signaling molecule can drive genetic and molecular pathways with implicated roles in ESC-osteogenic differentiation.
Conclusion
Our study demonstrated that the application of iNOS-loaded nanoparticles promoted ESC differentiation into the osteogenic lineage and identified putative genes and pathway networks involved in this osteoinduction. These findings provide a framework for identifying novel mechanisms by which iNOS/NO induces ESC-osteogenic differentiation. In addition, manipulating iNOS-derived NO signaling pathways using nanomaterials represent novel tools for the generation of lineage-committed cells for use in regenerative cell therapies. 
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